The results of this phase I study was encouraging with uPAR PET being able to identify both primary tumors and lymph node metastases in PC, although the limited number of patients precludes an evaluation of uPAR PET in the initial staging of PC. The gene discussed is PLAUR; the disease is metastatic malignant neoplasm in the lymph nodes.